Investigating how to modify a key enzyme involved in Alzheimer's disease
Molecular mechanisms of gamma-secretase modulation central to Alzheimer’s disease
This study is looking at how a specific enzyme related to Alzheimer's disease works, with the goal of finding new ways to lower harmful substances in the brain while keeping the enzyme functioning properly, which could help in developing better treatments for Alzheimer's.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10984494 on NIH RePORTER |
What this research studies
This research focuses on understanding the molecular mechanisms of γ-secretase, an enzyme that plays a crucial role in the production of β-amyloid peptides linked to Alzheimer's disease. By exploring how this enzyme's activity can be modulated, the research aims to develop new therapeutic agents that can selectively reduce harmful β-amyloid without disrupting the enzyme's overall function. The study employs an interdisciplinary approach, utilizing novel reagents and techniques to gain insights into the enzyme's behavior in different cellular contexts. This could lead to innovative strategies for treating or preventing Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of or diagnosed with Alzheimer's disease.
Not a fit: Patients with other forms of dementia unrelated to β-amyloid production may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that effectively reduce the progression of Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in targeting γ-secretase modulation, indicating potential for success in this approach.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Li, Yueming — Sloan-Kettering Inst Can Research
- Study coordinator: Li, Yueming
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.